The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Improving safety in first-line metastatic colorectal cancer (MCRC) therapy with bevacizumab: Modified FOLFOX7 versus XELOX2—Results of the induction phase of the GERCOR DREAM randomized phase III study.
 
Christophe Tournigand
Consulting or Advisory Role - Roche
 
Benoist Chibaudel
Consulting or Advisory Role - Roche; Sanofi
Travel, Accommodations, Expenses - Roche
 
Benoit Samson
No Relationships to Disclose
 
Werner Scheithauer
No Relationships to Disclose
 
Gérard Lledo
No Relationships to Disclose
 
Pascal Artru
No Relationships to Disclose
 
Frédéric Viret
No Relationships to Disclose
 
Jean-Francois RAMEE
No Relationships to Disclose
 
Nicole Tubiana-Mathieu
No Relationships to Disclose
 
Jérôme Dauba
No Relationships to Disclose
 
Olivier Dupuis
No Relationships to Disclose
 
Yves Rinaldi
No Relationships to Disclose
 
May Mabro
No Relationships to Disclose
 
Nathalie Aucoin
No Relationships to Disclose
 
Franck Bonnetain
Honoraria - Amgen; Bayer; Lilly; Merck Serono; Novartis; Vifor Pharma
Consulting or Advisory Role - Amgen; Celgene; Roche; Sanofi
Research Funding - Amgen; Celgene
 
Christophe Louvet
Consulting or Advisory Role - Celgene; Nucana; Pfizer; Roche; Sanofi
 
Annette K. Larsen
No Relationships to Disclose
 
Thierry André
Honoraria - Roche
Consulting or Advisory Role - Amgen; Bayer; Roche
 
Aimery De Gramont
Consulting or Advisory Role - Roche; Sanofi
Speakers' Bureau - Roche; Sanofi